<DOC>
	<DOCNO>NCT00261599</DOCNO>
	<brief_summary>Very often patient receive medication diagnostic procedure , like colonoscopy , help relax stay calm procedure . This call procedural minimal-to-moderate sedation . One product use sedation call propofol . AQUAVAN ( fospropofol disodium ) make water soluble form propofol allow rapid sedation entire procedure . This study design test AQUAVAN sedation colonoscopy procedure .</brief_summary>
	<brief_title>An Effectiveness Safety Study AQUAVAN® Injection ( Fospropofol Disodium ) Sedation During Colonoscopy</brief_title>
	<detailed_description>This phase 3 , randomize , double-blind , dose-controlled study design evaluate efficacy safety moderate dose AQUAVAN compare subtherapeutic dose AQUAVAN , follow pretreatment analgesic fentanyl , patient undergo elective colonoscopy . A group patient receive midazolam reference therapy . Following completion pre-procedure assessment , patient randomly assign 1 3 treatment group 2:3:1 ( AQUAVAN initial dose 1 [ subtherapeutic dose ] : AQUAVAN initial dose 2 [ moderate dose ] : initial Midazolam Reference Dose ) allocation ratio day schedule procedure . A person skilled airway management authorized facility colonoscopy perform ( respiratory therapist , study nurse , clinician ) must immediately available conduct study . All patient place supplemental oxygen via nasal cannula ( 4 L/min ) , ECG monitor , pulse oximeter , blood pressure monitor attach prior administration study medication . All patient receive injection analgesic pretreatment follow administration study medication . This protocol recognize 2 distinct phase sedation : Sedation Initiation Sedation Maintenance . Assessments make evaluate patient level sedation , clinical benefit sedation , adverse event . Blood sample collect PK analysis .</detailed_description>
	<mesh_term>Fospropofol</mesh_term>
	<mesh_term>Propofol</mesh_term>
	<mesh_term>Midazolam</mesh_term>
	<criteria>Number patients/site : Approximately 300 patient 30 site randomize study . Study Country Location : United States 1 . Patient must able understand require assessment procedure . 2 . Patient provide signed/dated Informed Consent Health Insurance Portability Accountability Act 1996 ( HIPAA ) authorization receive full explanation extent nature study . 3 . Patient must least 18 year age time screen . 4 . If female , patient must surgically sterile , postmenopausal , pregnant lactating must use acceptable method birth control least 1 month prior dose , negative urine pregnancy test result screen predose . 5 . Patient meet American Society Anesthesiologists ( ASA ) Physical Classification System status P1 P4 . 1 . Patient history allergic reaction hypersensitivity anesthetic agent , opioid , benzodiazepine . 2 . Patient meet nil per o ( NPO ) status per ASA guideline institution 's guideline . 3 . Patient Mallampati Classification Score 4 ; OR Mallampati Classification Score 3 AND thyromental distance ≤4 cm , reason difficult airway , opinion Investigator . 4 . Patient abnormal , clinically significant 3lead ECG find predosing period Day 0 . 5 . Patient participate investigational drug study within 1 month prior study start . 6 . Patient unwilling adhere pre postprocedural instruction . 7 . Patient use fentanyl citrate injection ( fentanyl ) contraindicate . 8 . Patient use midazolam HCl injection ( midazolam ) contraindicate .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2008</verification_date>
	<keyword>Colonoscopy</keyword>
	<keyword>Sedation</keyword>
	<keyword>AQUAVAN</keyword>
	<keyword>Fospropofol disodium</keyword>
	<keyword>Colon polyp</keyword>
	<keyword>Endoscopic outcome</keyword>
	<keyword>Endoscopic sedation</keyword>
	<keyword>Endoscopy</keyword>
</DOC>